Lv617
1700 积分 2021-03-29 加入
Trispecific antibodies in cancer therapy: Mechanisms, clinical progress and future directions
1天前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
1天前
求助中
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
1天前
已完结
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity
2天前
已完结
Hydrophobic interaction chromatography for the characterization of monoclonal antibodies and related products
6天前
已完结
Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool
6天前
已完结
Development issues: antibody stability, developability, immunogenicity, and comparability
8天前
已完结
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer
9天前
已完结
Mapping the patent landscape of TROP2-targeted biologics through deep learning
10天前
已完结
Cloning of the gene encoding TROP‐2, a cell‐surface glycoprotein expressed by human carcinomas
11天前
已完结
皖公网安备34019202002308
